Research and analysis

Multi-drug resistant gonorrhoea in England: 2018

Microbiological and epidemiological information relating to multi-drug resistant gonorrhoea (MDRGC) in England, the first case being reported in March 2018.

Documents

Update on investigation of UK case of Neisseria gonorrhoeae with high-level resistance to azithromycin and resistance to ceftriaxone acquired abroad

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

UK case of Neisseria gonorrhoeae with high-level resistance to azithromycin and resistance to ceftriaxone acquired abroad

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This is the first global report of N. gonorrhoeae with high-level resistance to azithromycin and resistance to ceftriaxone.

Public Health England (PHE) reminded clinical laboratories to refer N. gonorrhoeae isolates with resistance to ceftriaxone (MIC >0.125 mg/L) or azithromycin (MIC >0.5 mg/L) to the PHE Reference Bacteriology at Colindale for confirmation; General Practitioners were reminded to refer all suspected cases of gonorrhoea to genitourinary medicine services for appropriate management according to PHE guidance.

Published 27 March 2018
Last updated 20 April 2018 + show all updates
  1. Added HPR 12(14) first update report.
  2. First published.